Axsome 治療公司
DE ˙ DB ˙ US05464T1043
€199.30 ↑9.50 (5.01%)
2026-06-04
分享價格
SecurityDE:19X / Axsome Therapeutics, Inc.
InstitutionStrs Ohio
Latest Disclosed Ownership10,500 shares
Latest Disclosed Value $ 1,774,710
Strs Ohio reports 2.78% decrease in ownership of 19X / Axsome Therapeutics, Inc.

On April 24, 2026 - Strs Ohio filed a 13F-HR form disclosing ownership of 10,500 shares of Axsome Therapeutics, Inc. (DE:19X) valued at $1,473,150 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 10,800 shares of Axsome Therapeutics, Inc.. This represents a change in shares of -2.78% during the quarter. The current value of the position is $2,092,650 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F AXSOME THERAPEUTICS COM_STK 05464T104 10,500 -300 -2.78 1,775 -10.04 0.0070
2026-02-02 2025-12-31 13F AXSOME THERAPEUTICS COM_STK 05464T104 10,800 -1,100 -9.24 1,973 36.47 0.0074
2025-10-30 2025-09-30 13F AXSOME THERAPEUTICS COM_STK 05464T104 11,900 -200 -1.65 1,445 14.41 0.0053
2025-08-04 2025-06-30 13F AXSOME THERAPEUTICS COM_STK 05464T104 12,100 1,700 16.35 1,263 4.21 0.0047
2025-05-28 2025-03-31 13F AXSOME THERAPEUTICS COM_STK 05464T104 10,400 5,800 126.09 1,213 211.57 0.0051
2025-05-28 2024-12-31 13F AXSOME THERAPEUTICS COM_STK 05464T104 4,600 0 0.00 389 -5.81 0.0015
2024-11-01 2024-09-30 13F AXSOME THERAPEUTICS COM_STK 05464T104 4,600 1,800 64.29 413 83.56 0.0016
2024-08-05 2024-06-30 13F AXSOME THERAPEUTICS COM_STK 05464T104 2,800 -1,600 -36.36 225 0.0009
2024-05-13 2024-03-31 13F AXSOME THERAPEUTICS COM_STK 05464T104 4,400 -1,600 -26.67 0 0.0014
2024-01-30 2023-12-31 13F AXSOME THERAPEUTICS COM 05464T104 6,000 -3,500 -36.84 0 0.0020
2023-10-26 2023-09-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 9,500 2,100 28.38 1 0.0030
2023-10-26 2023-09-30 13F AXSOME THERAPEUTICS COM 05464T104 9,500 2,100 1 0.0030
2023-07-31 2023-06-30 13F AXSOME THERAPEUTICS COM 05464T104 7,400 700 10.45 1 0.0022
2023-08-02 2023-03-31 13F/A-2 AXSOME THERAPEUTICS COM 05464T104 6,700 2,900 76.32 0 0.0018
2023-08-02 2023-03-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 6,700 2,900 0 0.0018
2023-04-27 2023-03-31 13F AXSOME THERAPEUTICS COM 05464T104 6,700 2,900 0 0.0021
2023-01-26 2022-12-31 13F AXSOME THERAPEUTICS COM 05464T104 3,800 3,800 0 0.0013
2022-04-21 2022-03-31 13F AXSOME THERAPEUTICS COM 05464T104 0 -4,600 -100.00 0 -100.00
2022-01-24 2021-12-31 13F AXSOME THERAPEUTICS COM 05464T104 4,600 -800 -14.81 173 -2.26 0.0006
2021-10-22 2021-09-30 13F AXSOME THERAPEUTICS COM 05464T104 5,400 5,400 177 0.0007
2021-04-23 2021-03-31 13F AXSOME THERAPEUTICS COM 05464T104 0 -1,100 -100.00 0 -100.00
2021-01-25 2020-12-31 13F AXSOME THERAPEUTICS COM 05464T104 1,100 -7,700 -87.50 89 -85.81 0.0003
2020-12-14 2020-09-30 13F AXSOME THERAPEUTICS COM 05464T104 8,800 0 0.00 627 -13.40 0.0026
2020-07-23 2020-06-30 13F AXSOME THERAPEUTICS COM 05464T104 8,800 5,000 131.58 724 224.66 0.0032
2020-04-23 2020-03-31 13F AXSOME THERAPEUTICS COM 05464T104 3,800 3,800 223 0.0012
2017-07-26 2017-06-30 13F AXSOME THERAPEUTICS COM 05464T104 0 -3,600 -100.00 0 -100.00
2017-04-26 2017-03-31 13F AXSOME THERAPEUTICS COM 05464T104 3,600 0 0.00 14 -41.67 0.0001
2017-01-24 2016-12-31 13F AXSOME THERAPEUTICS COM 05464T104 3,600 0 0.00 24 -14.29 0.0001
2016-10-27 2016-09-30 13F AXSOME THERAPEUTICS COM 05464T104 3,600 -100 -2.70 28 3.70 0.0001
2016-07-26 2016-06-30 13F AXSOME THERAPEUTICS COM 05464T104 3,700 3,700 27 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.